Literature DB >> 18681944

The role of mast cells in eosinophilic esophagitis.

Alfredo J Lucendo1, Teresa Bellón, Baltasar Lucendo.   

Abstract

Eosinophilic esophagitis (EE) is a chronic inflammatory disease of the esophagus which is characterized by the presence of dense infiltrate of eosinophilic leukocytes restricted to this organ mucosa. Accumulating published evidence suggests a strong role of mast cells in the inflammatory infiltrate in the physiopathology of EE. We have reviewed published articles with relevant information about the presence and possible role of mast cells in EE. Although mast cells have been studied indirectly in EE, reported data allow us to confirm that the number of mast cells infiltrating the esophageal epithelium in adult and child patients with EE is higher with respect to the normal state and in gastroesophageal reflux disease. Mast cells linked to IgE, which are not found in other conditions, have been identified in EE. Despite that fact, an anaphylactic reaction history after exposure to allergens is not common in these patients. Therefore, the mast cells' function in EE could be dependent on T lymphocytes, as suggested by a mast cell gene expression analysis. Bi-directional crosstalk is established between mast cells and eosinophils, hence establishing interesting hypotheses regarding their relationship to EE physiopathology. Mast cells' function as an immune response leader seems to substitute for their effector functions in EE, while at the same time opening new research pathways for consideration of these cells as a therapeutic target in EE. However, the inefficiency of therapies that inhibit mast cell functions while they are effective in other respiratory tract diseases results in the need for specific studies to identify the real function of such complex cells in the physiopathology of EE. There is indirect proof of the role of mast cells in EE, while many doubts exist about their activation mechanism, which does not seem to be IgE-mediated. Specific approach studies are needed to clarify the function of these cells in the physiopathology of EE, which could be a possible therapeutic target.

Entities:  

Mesh:

Year:  2008        PMID: 18681944     DOI: 10.1111/j.1399-3038.2008.00798.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  18 in total

1.  Involvement of mast cells in eosinophilic esophagitis.

Authors:  J Pablo Abonia; Carine Blanchard; Bridget Buckmeier Butz; Heather F Rainey; Margaret H Collins; Keith Stringer; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

2.  Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease.

Authors:  Evan S Dellon; Xiaoxin Chen; C Ryan Miller; Karen J Fritchie; Tara C Rubinas; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2010-10-26       Impact factor: 10.864

3.  Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.

Authors:  Alfredo J Lucendo; Livia C De Rezende; Susana Jiménez-Contreras; Jose Luis Yagüe-Compadre; Jesús González-Cervera; Teresa Mota-Huertas; Danila Guagnozzi; Teresa Angueira; Sonia González-Castillo; Angel Arias
Journal:  Dig Dis Sci       Date:  2011-06-15       Impact factor: 3.199

4.  Meta-Analysis-Based Guidance for Dietary Management in Eosinophilic Esophagitis.

Authors:  Alfredo J Lucendo
Journal:  Curr Gastroenterol Rep       Date:  2015-10

5.  Diagnostic and therapeutic strategies for eosinophilic esophagitis.

Authors:  Asifa K Zaidi; Ahad Mussarat; Anil Mishra
Journal:  Clin Pract (Lond)       Date:  2014

Review 6.  An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.

Authors:  Zahra Ahmadi; Gholamhossein Hassanshahi; Hossein Khorramdelazad; Nahid Zainodini; Leila Koochakzadeh
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

Review 7.  Eosinophilic esophagitis: New insights in pathogenesis and therapy.

Authors:  Michele Pier Luca Guarino; Michele Cicala; Jose Behar
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

8.  Validation of methods to assess potential biomarkers in pediatric patients with esophageal eosinophilia.

Authors:  Jennifer M Colombo; Nancy A Neilan; Jennifer Verrill Schurman; Craig A Friesen
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

Review 9.  Eosinophilic esophagitis: the newest esophageal inflammatory disease.

Authors:  Dan Atkins; Robert Kramer; Kelley Capocelli; Mark Lovell; Glenn T Furuta
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

10.  Contribution of endoscopy in the management of eosinophilic esophagitis.

Authors:  Cristina Targa Ferreira; Helena As Goldani
Journal:  World J Gastrointest Endosc       Date:  2012-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.